MYRIAD GENETICS, INC. Business Acquisition, Pro Forma Net Income (Loss)
MYRIAD GENETICS, INC. (MYGN) reported Business Acquisition, Pro Forma Net Income (Loss) of $6.90 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2019-05-08
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2019-03-31 was $6.90M.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-12-31 was $2.60M, a 80.30% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-09-30 was $8.60M, a 85.97% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-03-31 was -$1.20M, a 128.57% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for fiscal 2017 was $1.20M, a 98.12% decline from fiscal 2016.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for fiscal 2016 was $63.70M, a 20.57% decline from fiscal 2015.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for fiscal 2015 was $80.20M, a 48.56% decline from fiscal 2014.
- MYRIAD GENETICS, INC. business acquisition, pro forma net income (loss) for fiscal 2014 was $155.90M, a 44.32% increase from fiscal 2013.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $6.90M 10-Q · filed 2019-05-08 | $9.50M derived: sum of 2 quarters · filed 2019-05-08 | $18.20M 10-Q · filed 2019-05-08 | |||||
| 2018-12-31 | $2.60M 10-Q · filed 2019-02-06 | $11.20M 10-Q · filed 2019-02-06 | ||||||
| 2018-09-30 | $8.60M 10-Q · filed 2018-11-07 | |||||||
| 2018-03-31 | -$1.20M 10-Q · filed 2019-05-08 | $11.40M 10-Q · filed 2018-05-09 | $12.00M derived: sum of 2 quarters · filed 2019-05-08 | $74.20M 10-Q · filed 2019-05-08 | $124.60M 10-Q · filed 2018-05-09 | $83.60M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $13.20M 10-Q · filed 2019-02-06 | $32.10M 10-Q · filed 2018-02-07 | $74.00M 10-Q · filed 2019-02-06 | $113.20M 10-Q · filed 2018-02-07 | $84.80M derived: sum of 3 quarters · filed 2019-02-06 | $89.00M derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-09-30 | $61.30M 10-Q · filed 2018-11-07 | $81.10M 10-Q · filed 2017-11-08 | $71.60M derived: sum of 2 quarters · filed 2018-11-07 | $75.80M derived: sum of 3 quarters · filed 2018-11-07 | $81.70M derived: sum of 4 quarters · filed 2018-11-07 | |||
| 2017-06-30 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $14.50M derived: sum of 2 quarters · filed 2018-08-24 | $20.40M derived: sum of 3 quarters · filed 2018-08-24 | $1.20M 10-K · filed 2018-08-24 | $2.50M 10-K · filed 2017-08-09 | |||
| 2017-03-31 | $4.20M 10-Q · filed 2018-05-09 | $10.10M derived: sum of 2 quarters · filed 2018-05-09 | -$9.10M 10-Q · filed 2018-05-09 | -$12.00M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-12-31 | $5.90M 10-Q · filed 2018-02-07 | -$13.30M 10-Q · filed 2018-02-07 | -$16.20M derived: sum of 3 quarters · filed 2018-08-24 | $7.40M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-09-30 | -$19.20M 10-Q · filed 2017-11-08 | -$22.10M derived: sum of 2 quarters · filed 2018-08-24 | $1.50M derived: sum of 3 quarters · filed 2018-08-24 | $25.00M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-06-30 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $20.70M derived: sum of 2 quarters · filed 2018-08-24 | $44.20M derived: sum of 3 quarters · filed 2018-08-24 | $63.70M 10-K · filed 2018-08-24 | $71.80M 10-K · filed 2017-08-09 | |||
| 2016-03-31 | $23.60M 10-Q · filed 2017-05-03 | $47.10M derived: sum of 2 quarters · filed 2017-05-03 | $66.60M 10-Q · filed 2017-05-03 | $85.31M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | $23.50M 10-Q · filed 2017-02-08 | $43.00M 10-Q · filed 2017-02-08 | $61.71M derived: sum of 3 quarters · filed 2017-02-08 | $83.19M derived: sum of 4 quarters · filed 2017-02-08 | ||||
| 2015-09-30 | $19.50M 10-Q · filed 2016-11-02 | $38.21M derived: sum of 2 quarters · filed 2016-11-02 | $59.69M derived: sum of 3 quarters · filed 2016-11-02 | $83.72M derived: sum of 4 quarters · filed 2016-11-02 | ||||
| 2015-06-30 | $18.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $40.19M derived: sum of 2 quarters · filed 2015-08-12 | $64.22M derived: sum of 3 quarters · filed 2015-08-12 | $80.20M 10-K · filed 2015-08-12 | ||||
| 2015-03-31 | $21.48M 10-Q · filed 2015-05-06 | $45.51M derived: sum of 2 quarters · filed 2015-05-06 | $61.49M 10-Q · filed 2015-05-06 | $95.07M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-12-31 | $24.03M 10-Q · filed 2015-02-04 | $40.01M 10-Q · filed 2015-02-04 | $73.60M derived: sum of 3 quarters · filed 2015-08-12 | $102.77M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-09-30 | $15.98M 10-Q · filed 2014-11-05 | $49.57M derived: sum of 2 quarters · filed 2015-08-12 | $78.74M derived: sum of 3 quarters · filed 2015-08-12 | $126.17M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-06-30 | $33.58M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $62.76M derived: sum of 2 quarters · filed 2015-08-12 | $110.19M derived: sum of 3 quarters · filed 2015-08-12 | $155.90M 10-K · filed 2015-08-12 | $155.92M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $29.17M 10-Q · filed 2015-05-06 | $76.61M derived: sum of 2 quarters · filed 2015-05-06 | $122.32M 10-Q · filed 2015-05-06 | $154.91M derived: sum of 4 quarters · filed 2015-05-06 | ||||
| 2013-12-31 | $47.43M 10-Q · filed 2015-02-04 | $92.80M 10-Q · filed 2015-02-04 | $125.74M derived: sum of 3 quarters · filed 2015-02-04 | $154.36M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-09-30 | $45.37M 10-Q · filed 2014-11-05 | $78.30M derived: sum of 2 quarters · filed 2014-11-05 | $106.92M derived: sum of 3 quarters · filed 2014-11-05 | |||||
| 2013-06-30 | $32.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $61.55M derived: sum of 2 quarters · filed 2014-08-13 | $108.02M 10-K · filed 2014-08-13 | |||||
| 2013-03-31 | $28.62M 10-Q · filed 2014-05-07 | $75.09M 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |